A risk score for predicting peripheral arterial disease in individuals 75 years or older by Makdisse, Marcia et al.
Original Article
A Risk Score for Predicting Peripheral Arterial Disease in Individuals 
75 Years or Older
Marcia Makdisse, Luiz Roberto Ramos, Frederico Moreira, Anderson Oliveira, Otavio Berwanger, Alcione Moscardi, 
Virginia Junqueira, Evandro Rodrigues, Antonio Carlos Carvalho 
Universidade Federal de São Paulo, Hospital Israelita Albert Einstein - São Paulo, SP - Brazil
Summary
Background: The prevalence of peripheral arterial disease (PAD) in the elderly is high. Most are asymptomatic and the 
sensitivity of the physical exam is low. In Brazil, little is known in regard to PAD risk factors in the elderly.
Objectives: To identify risk factors for PAD among elderly individuals (≥ 75 years) in the community and to develop a 
prediction score.
Methods: Cross-sectional, prospective, community-based study nested within a cohort study (“Epidoso”). A total of 176 
individuals were assessed. PAD was defined as an ankle-brachial index ≤0.9. Risk factors associated with PAD were 
entered into a multivariate logistic regression model. Statistical modeling was used to formulate a score according to 
the likelihood of PAD. A p value <0.05 was significant.
Results: PAD was present in 36.4% of participants. Abnormal pedal pulses, hypertension, cigarette smoking, and 
complain of leg pain/discomfort in either leg on walking were predictors of PAD. Based on the coefficients of the 
logistic regression, these variables were given scores of 13, 9, 5 and 5, respectively. A cutoff point >18 points defined 
the “high risk” individuals and yielded sensitivity, specificity, positive predictive value and negative predictive value 
of 85.9%, 71.4%, 63.2% and 89.9%, respectively. Receiver-operator characteristic analysis yielded area under curve of 
85%, indicating excellent discrimination and goodness-of-fit statistics indicated excellent calibration (p=0.639).
Conclusion: Because of its good performance, the proposed score can become a simple and useful tool to identify 
elderly community residents at higher risk of PAD who should be considered for further investigation. (Arq Bras Cardiol 
2007;88(6):555-561)
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Introduction
The prevalence of Peripheral Arterial Disease (PAD) 
increases with age. In the NHANES study, the PAD prevalence 
for patients over the age of 70 was 14 times higher than for 
individuals under the age of 501. Among the 3,450 elderly 
American men of Japanese descent evaluated in the Honolulu 
Heart Program, the presence of PAD, defined as an ankle-
brachial index (ABI) ≤ 0.90, was a marker of generalized 
atherosclerotic disease2.  The rates of concomitant coronary 
artery disease and ischemic stroke with PAD reported for 
octogenarians are 68% and 42%, respectively3. PAD is 
associated with higher cardiovascular morbidity and mortality 
and functional impairment in the lower limbs regardless of 
whether the patient is symptomatic or asymptomatic4,5.
Even though the elderly population is a high risk group for 
PAD, identifying patients with the disease is not always simple. 
The medical history and clinical examination have limited 
value. Most patients, especially the older ones, do not present 
intermittent claudication, a classic symptom of the disease6. If 
the PAD diagnosis were based solely on the presence of typical 
intermittent claudication, 85 to 90% of the cases would go 
undetected and if it were based solely on the medical exam 
half of the cases would go undetected7-8. The ABI is a simple 
and cost-effective test for monitoring PAD in clinical practice; 
however more widespread use of this test is required9. 
The aim of the PAD risk score proposed in this study is to 
identify individuals 75 years or older living in the community, 
who are at greater risk to develop PAD and should be 
submitted to more thorough assessments including the ABI 
measurement.
Methods
Design - Cross-sectional study, nested in a cohort study 
(Epidoso Study).
Population - The patients were selected from the Epidoso 
Study (Epidemiologia do Idoso) the first Community-based 
longitudinal study conducted on an elderly population in 
Brazil. After a census was taken in the Saúde District, one 
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of the 55 districts in the city of Sao Paulo, all residents 65 
or older were invited to participate in the study. The study 
area was the catchment area of Federal University of São 
Paulo Center for the Study of Aging. The original cohort 
consisted of 1,667 individuals who were recruited in 1991. 
The methods and preliminary results of the Epidoso Study 
have been published10-11. 
Eligibility - 
• Inclusion criteria: Male and female participants of the 
Epidoso study. 
• Exclusion criteria:
- Conditions that impaired ABI measurement: amputation, 
extensive ulcerations, fractures, pain in lower limbs, severe 
cognitive impairment, patient refusal;
- ABI > 1.40. These values indicate non-compressible leg 
arteries and are non-diagnostic of PAD.
Study participants - The Epidoso participants that fulfilled 
the eligibility criteria and signed the consent form were 
included in the study. The project was approved by the Ethics 
Committee of the Federal University of São Paulo.
Case definition - 
• Presence of PAD: ABI values of 0.90 or less in either leg.
• Absence of PAD: ABI values between 0.91 and 1.40 in the 
absence of previous lower extremity arterial revascularization 
procedures. 
Definition of intermittent claudication - The presence 
of intermittent claudication was evaluated using the 
Brazilian Portuguese Version of the Edinburgh Claudication 
Questionnaire12.
Definition of pain/discomfort in either while walking - This is 
the first question on the Edinburgh Claudication Questionnaire 
which was analyzed as an independent variable. A positive 
response determined the presence of the symptom.
Definition of abnormal pedal pulses - The pulses were 
bilaterally palpated on the dorsalis pedis and posterior tibial 
arteries and classified as present, absent or asymmetrical. 
The pulses, even though they were present, were considered 
asymmetrical when the intensity of the pulse was different in 
the opposite limb.
Data collection - The patient’s clinical data were obtained 
from the Epidoso databank and included demographics, risk 
factors, comorbidities, laboratory and imaging tests. 
ABI measurement - After 5 minutes of bed rest, ABI was 
measured in the supine position using a hand-held vascular 
Doppler (10 Mhz, Medmega, Brazil) and an aneroid blood 
pressure device. The cuff size was selected according to the 
participant’s right arm circumference (AC) at the midpoint 
between the acromion and olecranon. Inflatable cuffs in the 
following lengths were used: AC < 25 cm – 10cm, AC from 
25-32 cm – 12cm, AC >32-42 cm – 16cm and AC > 42 cm 
– 20cm. Systolic blood pressure was measured for the brachial, 
dorsalis pedis and posterior tibial arteries. Two readings were 
taken for each artery and the average was calculated. If the 
difference between the two readings was > 6 mmHg, two 
more readings were taken. An ABI value was calculated for 
each lower limb, using the highest systolic pedal pressure 
reading divided by the highest brachial pressure reading13. 
Laboratory tests - The lipid profile, creatinine and 
homocysteine levels were obtained from the Epidoso 
databank.
Statistical analysis - Univariate logistic regression analysis 
was used to determine the association between risk factors and 
outcome (presence of PAD). Variables that presented p<0.25, 
were included in a multivariate logistic regression model with 
backward stepwise elimination. Variables that attained a level 
of significance (p<0.05) were kept in the model14. The final 
multivariate regression model was obtained using the forward 
stepwise variable selection method, where variables with 
p<0.25 were initially included and variables with p<0.05 
were kept in the model.
A weighted risk score was constructed using logistic 
regression coefficients. These coefficients were converted into 
scores (multiplied by 10 and rounded off to the nearest whole 
number) that were added up to obtain an aggregated score15. 
Two performance indexes were used to estimate the 
discriminatory power and calibration of the predictive model. 
The discriminatory power was evaluated using the area under 
the ROC curve (receiver operating characteristic curve)16 and 
the calibration was measured using the Hosmer-Lemeshow 
goodness-of-fit test17. According to Hosmer-Lemeshow, areas 
under the curve between 80% and 90% are consistent with 
excellent discriminatory power and calibration is adequate if 
the Hosmer-Lemeshow statistics has a p value of > 0.0514. 
The optimum cut-off point for the score was determined 
using the score values plotted on the ROC curve. Significance 
was established as p < 0.05. All statistical analysis were 
performed using SAS (Statistical Analysis System), version 8.2 
(SAS Institute, Cary, NC).
This study was funded by CAPES (Coordenação de 
Aperfeiçoamento de Pessoal de Nível Superior) and the 
EPIDOSO Study by FAPESP (Fundação de Amparo à Pesquisa 
do Estado de São Paulo).
Results
From the 226 patients invited to participate in the study, 178 
(78.8%) accepted. Reasons for not participating in the study 
included severe cognitive impairment, long-term institutional 
care and change of address. Two of the patients who agreed 
to participate in the study were excluded as they had an ABI 
> 1.40 (1.1%) resulting in a final sample size of 176. The PAD 
prevalence was 36.4% (n=64). Mean participant age was 82.7 
± 4.04 years (range: 75-94) which, although not statistically 
significant, was slightly higher in the PAD group (83.4 ± 4.2 
years and 82.2 ± 4.2 years, p=0.07). Women predominated 
(68.7%); but PAD prevalence was similar for both genders 
(33.9% females and 41.8% males, p=0.311). 
Univariate logistic regression - The results of the univariate 
analysis are shown in Table 1. Smoking was analyzed as a sum 
of current and previous smokers due to the small percentage 
of current smokers in the sample (total of 11 current smokers, 
7 with PAD).
Roughly 10% of the population were unable to walk 
(n=17). The complaint of pain or discomfort in one or both 
556
Original Article
Makdisse et al
Score to predict peripheral arterial disease
Arq Bras Cardiol 2007; 88(6) : 555-561
Table 1 - Univariate analysis of the clinical parameters of the 176 elderly patients (≥ 75 years)  
in relation to the presence of peripheral arterial disease (PAD)
Variable (n,%)
Total
(n=176)
PAD 
present
(n=64)
PAD  
absent
(n=112)
Estimated 
regression 
coefficient 
(standard 
deviation)
Odds ratio
(CI 95%)
p
Age, years
75-79 54(30.7) 17(26.5) 37(33.0) - 1.0(ref.)
80-84 64(36.4) 22(34.4) 42(37.5) -0.2(0.3) 1.1(0.5-2.5) 0.401
85-89 43(24.4) 17(26.5) 26(23.2) 0.004(0.3) 1.4(0.6-3.3) 0.989
≥ 90 15(8.5) 8(12.5) 7(6.3) 0.6(0.4) 2.5(0.8-7.9) 0.168
Gender
Female 121(68.7) 41(64.1) 80(71.4) - 1.1.0(ref.)
Male 55(31.3) 23(39.9) 32(28.6) 0.2(0.2) 0.7(0.4-1.4) 0.311
Body mass index (BMI), kg/m2
<25 74(42.0) 28(43.7) 46(41.1) - 1.1.0(ref.)
25-29.9 72(40.9) 24(37.5) 48(42.9) -0.1(0.2) 0.8(0.4-1.6) 0.468
≥30 30(17.0) 12(18.7) 18(16.1) 0.1(0.3) 1.1(0.5-2.6) 0.645
Systolic BP, mmHg
<140 34(19.3) 10(15.6) 24(21.4) - 1.1.0 (ref.)
140-159 52(29.5) 15(23.4) 37(33.0) -0.2(0.3) 0.9(0.4-2.5) 0.377
≥160 90(51.1) 39(60.9) 51(45.5) 0.4(0.2) 1.9(0.8-4.5) 0.054
Pulse abnormalities*
Yes 113(64.2) 59(92.2) 54(48.2) 1.3(0.3) 12.7(4.7-33.9) <0.0001
No 63(35.8) 5(7.8) 58(51.79) - 1.0(ref.)
Coexistent artery disease†
Yes 38(21.5) 21(32.8) 17(15.2) 0.5(0.2) 2.7(1.3-5.7) 0.007
No 138(78.4) 43(67.2) 95(84.8) - 1.0(ref.)
Smoking
Prior or current 59(33.5) 30(46.9) 29(25.9) 0.5(0.2) 2.5(1.3-4.8) 0.005
Never smoked 117(66.5) 34(53.1) 83(74.1) - 1.0(ref.)
Hypertension
Yes 121(68.7) 56(87.5) 65(58.0) 0.81(0.2) 5.1(2.2-11.6) 0.0001
No 55(31.3) 8(12.5) 47(41.9) - 1.0(ref.)
Diabetes mellitus
Yes 36(20.5) 17(26.5) 19(16.9) 0.28(0.2) 1.8(0.8-3.7) 0.131
No 140(79.5) 47(73.4) 93(83.0) - 1.0(ref.)
Family history of artery disease‡
Yes 29(16.5) 9(14.1) 20(17.9) 0.14(0.2) 0.7 (0.3-1.8) 0.515
No 147(83.5) 55(85.9) 92(82.1) - 1.0(ref.)
Dyslipidemia§
Yes 90(51.1) 35(54.7) 55(49.1) 0.11(0.2) 1.3(0.7-2.3) 0.476
No 86(48.9) 29(45.3) 57(50.9) - 1.0(ref.)
Sedentary lifestyle//
Yes 76(43.2) 30(46.9) 46(41.1) 0.12(0.16) 1.3(0.7-2.3) 0.455
No 100(56.8) 34(53.1) 66(58.9) - 1.0(ref.)
Pain/discomfort in one or both legs while walking
Yes 61(34.7) 32(50.0) 29(25.9) 0.5(0.2) 2.9(1.5-5.5) 0.001
No 115(65.3) 32(50.0) 83(74.1) - 1.0(ref.)
*Dorsalis pedis and/or posterior tibial pulses absent or asymmetrical. †Documentation of coronary artery disease, stroke, aneurism of the abdominal aorta 
or carotid stenosis. ‡ 1st degree relative with PAD or ≥ 1 of the conditions described above. § Total cholesterol levels ≥ 240 mg/dl and/or HDL cholesterol 
≤40 and/or LDL cholesterol ≥160 mg/dl and/or triglycerides ≥ 200 mg/dl and/or current/previous use of hipolipidemic agents. //Walk or perform any 
other exercise < 90 minutes per week, regardless of the frequency.
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legs while walking was more frequent than intermittent 
claudication (37.7% versus 15.9%). Concomitant leg pain/
discomfort in either leg at rest was the reason for not meeting 
the claudication criteria for 80% of the elderly patients with 
PAD. To avoid the effect of various confounding variables, two 
separate univariate regression models were used, one including 
pain/discomfort in either leg while walking and another 
including claudication. The two variables were associated 
with PAD (p=0.001 and p <0.0001, respectively). Due to 
the low prevalence of claudication and the independent 
association between PAD and pain/discomfort in either leg 
while walking, the latter variable was maintained in the final 
logistic regression model.
No association was found between PAD and total 
cholesterol, LDL cholesterol, HDL cholesterol or triglyceride 
levels. The PAD group presented higher homocysteine and 
serum creatinine levels. After adjustment for creatinine levels 
no association was found between homocysteine levels and 
PAD (Table 2).
Multivariate logistic regression - The independent predictor 
variables of PAD are shown in Table 3. 
Risk score calculation - A numerical score was formulated 
using logistic regression coefficients. Abnormal pedal pulse 
palpation, hypertension, current or prior smoking and pain 
or discomfort in either leg while walking received scores of 
13, 9, 5 and 5, respectively. Based on the classification table, 
derived from the logistic regression, and ROC curve analysis, 
the optimal cut-off point for the prediction of PAD resulted 
from a pre-test probability of 0.34, equivalent to a score > 
Table 3 - Logistic regression analysis of the clinical parameters related to peripheral artery disease
Variable
Estimated 
regression 
coefficient 
(standard 
deviation)
Odds 
ratio
CI 95% p
Score
(points)
Abnormal pedal pulses 1.3(0.3) 14.1 4.9-40.4 <0.0001 13
Hypertension 0.9(0.2) 6.1 2.4-15.8 0.0002 9
Smoking (prior or current) 0.5(0.2) 2.9 1.3-6.6 0.010 5
Pain/discomfort in either leg while walking 0.5(0.2) 2.5 1.1-5.5 0.025 5
Table 2 - Univariate analysis of the laboratory parameters of the 176 elderly patients (≥ 75 years)  
in relation to the presence of peripheral artery disease (PAD)
Variable (n,%)
Total
(n=176)
PAD present
(n=64)
PAD absent
(n=112)
p
Total Cholesterol, mg/dl 224.1±39.9 227.2 ± 37.8 222.3 ± 41.2 0.428
LDL-cholesterol, mg/dl 140.9±33.2 143.7 ± 31.2 140.3 ± 33.1 0.505
HDL-cholesterol, mg/dl 52.9±13.6 51.4 ± 11.9 53.9 ± 14.5 0.245
Triglycerides, mg/dl 148.4±69.6 157.5 ± 81.3 143.2 ± 61.7 0.196
Homocysteinemia, µmol/l 16.1±7.8 17.9 ± 7.9 14.9 ± 7.5 0.007
Serum creatinine, mg/dl 1.1±0.2 1.18 ± 0.2 1.08 ±. 0.1 0.033
Homocysteinemia adjusted for creatinine - - - 0.29
18 points. Sensitivity, specificity, positive predictive value 
and negative predictive value were 85.9%, 71.4%, 63.2% 
and 89.9%, respectively. The equation used to calculate the 
PAD Risk Score for each patient was: PAD Risk Score = 13 
(abnormal pedal pulses) + 9 (hypertension) + 5 (prior or 
current smoking) + 5 (pain/discomfort in either leg while 
walking). For each of the items, a value of “1” was assigned 
if the variable was “present” or “0” if it was “absent”. If the 
total score was > 18, the individual was classified as “High 
risk for PAD”; otherwise, “Low Risk for PAD” (Table 4).
A ROC curve was plotted to test the ability of the score 
to correctly predict the presence of PAD. The sensitivity 
and specificity values for each score were plotted on a two 
dimensional graph (xy) where the y axis was equal to the 
sensitivity and the x axis was equal to 100-specificity. The area 
under the ROC curve was 85%, indicating excellent model 
discriminatory power (Figure 1). The goodness-of-fit test value 
was 5.17 with seven degrees of freedom, indicating excellent 
model calibration for the observed versus the predicted 
outcome (p=0.639). 
Discussion
The present study evaluated a cohort from the Epidoso 
Study, the first longitudinal study of a community-based older 
population in Brazil. After 11 years of follow-up, this cohort 
is composed of almost 70% of octogenarians, the fastest 
growing population segment in the world and one usually 
underrepresented in studies. Using an ABI threshold of ≤ 
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Table 4 - Distribution of the individuals, with and without peripheral 
artery disease (PAD) in relation to the risk score obtained
Risk 
Score
PAD 
present
n (%)
PAD 
absent
n (%)
Total
n (%)
0 0 (0.0) 14 (100.0) 14 (100.0)
5 0 (0.0) 6 (100.0) 6 (100.0)
9 2 (10.0) 18 (90.0) 20 (100.0)
10 0 (0.0) 3 (100.0) 3 (100.0)
13 4 (28.6) 10 (71.4) 14 (100.0)
14 1 (5.9) 16 (94.1) 17 (100.0)
18 2 (13.3) 13 (86.7) 15 (100.0)
19 2 (66.7) 1 (33.3) 3 (100.0)
22 14 (42.4) 19 (57.6) 33 (100.0)
23 2 (66.7) 1 (33.3) 3 (100.0)
27 23 (71.9) 9 (28.1) 32 (100.0)
32 14 (87.5) 2 (12.5) 16 (100.0)
Total 64 (36.4) 112 (63.6) 176 (100.0)
Fig. 1 - ROC (Receiver operator characteristic) Curve. The area under the curve 
was 85%, demonstrating the model’s excellent discriminatory power.
100 - Specificity
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en
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0.90, a high prevalence of PAD (36%) was found which agrees 
with the findings of other studies evaluating the elderly. In the 
Rotterdam study, for instance, the prevalence of PAD in those 
aged 85 years or older approached 60%18. 
Pedal pulses abnormalities, hypertension, prior or current 
smoking and pain/discomfort in either leg while walking were 
identified as independent predictors of PAD in the present 
study. Based on the regression coefficients, a numerical risk 
score was formulated to assess the individual likelihood of 
presenting PAD; it enabled the stratification of individuals 
into “high risk” (Total score > 18 points) or “low risk” (Total 
score ≤ 18 points) for the presence of PAD.
The presence of abnormal pedal pulses was the 
strongest predictor of PAD in this cohort (odds ratio = 
14.1). According to published data, pulse palpation is the 
single most important part of the physical examination in 
screening for PAD and abnormal pedal pulses a powerful 
predictor of the disease, even though the sensitivity and 
specificity of palpation may vary depending on factors 
related to the patient and the examiner19-21. 
Smoking, hypertension and diabetes mellitus are among the 
cardiovascular risk factors most consistently linked to PAD in 
studies that involved elderly cohorts2,3,22. In the present study, 
even though most of the diabetics were in the PAD group, no 
differences were observed between the groups (26.5% versus 
16.9%, p=0.131). This lack of association between diabetes 
and PAD could have been secondary to the mild diabetes 
profile presented by the patients (100% with diabetes for 
less than 10 years, 25% controlled with diet alone and only 
17% requiring insulin) that could have reduced the force of 
association between the two conditions, or sample size was 
perhaps insufficient to detect the difference, or both. 
The lack of association between dyslipidemia and PAD has 
already been reported. In the Honolulu Heart Program, PAD 
was associated with high and low cholesterol levels and in the 
GetABI study no clear association between cholesterol and 
PAD was observed2,23. These data suggest that in the elderly, 
cholesterol is more important as a marker of comorbidity 
overload than of cardiovascular risk. 
No association between a sedentary lifestyle and PAD was 
observed in our sample. The reduction in physical activity 
could be a result of functional impairment in the lower limbs 
provoked by PAD, which causes the patients to reduce physical 
activity2. The rate of physical inactivity in the present study 
was low (43%), considering the definition adopted (moderate 
physical activity < 90 minutes per week, regardless of the 
frequency) and the age profile of the population. In the Estudo 
Multicêntrico de Idosos (Multicenter Study of the Elderly) the 
sedentary lifestyle rate, even using the most lenient definition 
(physical activity < 15 minutes, 2 times per week) was 74%24. 
It is possible that the ten-plus year relationship with the 
interdisciplinary team of the Epidoso study, stimulated this 
population to perform physical exercise.
There was no association between BMI and PAD. In literature 
this association is controversial. Some studies, such as the 
Honolulu Heart Program, found an association whereas others, 
such as NHANES, did not9,15. In relation to homocysteine, 
the initial difference was eliminated after adjustments for 
creatinine. In the GetABI study, hyperhomocysteinemia, after 
adjustments for various factors including creatinine, had a weak 
association with PAD (odds ratio = 1.4)25. 
Although the degree of association between intermittent 
claudication and PAD was stronger than that between 
PAD and the presence of pain or discomfort in either leg 
while walking (odds ratio = 9.26 and 2.86, respectively) 
the latter symptom was held in the score due to its greater 
prevalence, the simplicity to obtain the data (one question 
versus a questionnaire) and the concomitant presence of pain/
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discomfort in the legs at rest in 80% of the patients with PAD 
that jeopardized the sensitivity of the Edinburgh questionnaire. 
This decision raised the score’s sensitivity, since the detection 
of claudication is affected by comorbidities that interfere in 
patient complaints, particularly the elderly, and reduces the 
sensitivity of the claudication questionnaires26.
Various interesting points can be raised in favor of the 
usefulness of this new risk score. In the first place, this is the 
first instrument for predicting PAD directed at the population 
over 75, and while this is a high risk group very few studies 
have been conducted on this population segment. The second 
point is to present a better association between sensitivity and 
specificity for the detection of the disease than that presented 
by pedal pulse palpation or the Edinburgh Claudication 
Questionnaire that were applied separately in this cohort 
(proposed score: 86% and 71%, abnormal pedal pulses: 92% 
and 52%, claudication using the Edinburgh questionnaire: 
34% and 94%, respectively).  
The third point is its simplicity since there are just four 
questions, three on the patient’s medical history and one 
on the physical exam. The combination of these variables 
was also the basis for other PAD detection scores. Among 
them, two are precise mathematical models, however they 
are very complex and complicated to be used during a 
consultation27-28, and one is derived from the Framingham 
Study to detect intermittent claudication; however due to the 
low prevalence of this symptom, its accuracy is jeopardized, 
especially in the elderly29.
The fourth point is the excellent performance obtained 
by the model both in relation to the power to distinguish 
individuals with and without PAD (area under the ROC curve 
= 85%), and the calibration demonstrated by the goodness-
of-fit test (5.2, p = 0.639).
Study limitations - This study has some limitations. Since 
only the survivors of the original cohort could be included, 
the sample size was limited and therefore only factors strongly 
related to PAD were detected. This fact could have, for 
example, concealed a weak association in this population 
between PAD and diabetes mellitus. Thus, this score could be 
a useful tool for screening PAD in non-diabetic elderly patients, 
that in itself is not a problem, since diabetics over the age of 50 
should be evaluated for PAD on a routine basis with the ABI 
test30. Further prospective validation of this score in different 
populations is required before it can be recommended for 
use in clinical practice. 
Clinical implications - The intent of the proposed risk score 
is to provide a simple triage tool to identify elderly individuals 
with high risk for PAD who should undergo more thorough 
investigations, especially in primary care facilities where the 
ankle-brachial index measurement is not widely available, 
which unfortunately is a reality in the majority of facilities in 
Brazil as well as in several other countries.
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